The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in immune-oncology era (SEVURO-CN): study protocol for a multi-center, prospective, randomized trial

Abstract Background The role of cytoreductive nephrectomy (CN) in the treatment of metastatic renal cell carcinoma (mRCC) remains unclear in the immuno-oncology (IO) era. The results of two randomized trials, CARMENA and SURTIME, questioned the role and timing of CN. However, despite the latest adva...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Jee Soo Park, Jongchan Kim, Jinhyung Jeon, Jongsoo Lee, Won Sik Jang, Seung Hwan Lee, Woong Kyu Han, Young Deuk Choi, Kyo Chul Koo, Kang Su Cho, Byung Ha Chung, Won Sik Ham
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMC 2024-07-01
Seri Bilgileri:	Trials
Konular:	Renal cell carcinoma Cytoreductive nephrectomy Ipilimumab Nivolumab Immune checkpoint inhibitors Kidney neoplasms
Online Erişim:	https://doi.org/10.1186/s13063-024-08234-2
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!